We are fast growing company with a wide range of Pharmaceutical Products   

Chairman & Managing Director's Message -  ( 20th April 2015 )
Chairman & Managing Director's Message (20th April 2015) :

Welcome to 9th Annual General Meeting of "Oriscon Biotech (I) Pvt Ltd." I would like to take this opportunity to briefly address you on the position of your company. It has been a very eventful year for the company I say this confidently because:

Your Company has a robust financial position , which provides the means to deliver the strategy. Investment return for the year has been satisfactory as it is evident from the fact that your Company has already decided to pay a return of 14% to all the Promoters / Members as per the respective agreements according to their share holdings.

In the year under review, our 9th consecutive record result , your company produced an increase in capital base after Tax and benefits attributable to Promoters/ shareholders.While it is still early days of  organisational development, despite that your company is making solid progress.

we remain very focused on the key priorities of Institutional Generic Business that will ultimately unlock shareholder's value. As it transpires with the facts that your Company's present value of equity share of INR 10 increases to INR 100 for any new or further allotment of shares to its associates. I would like to thank all the loyal and dedicated people who put forwarded their faith and whole hearted effort for the development of the company since its inception.

Company's financial results for the financial year ended 31st March 2015 are summarised below: 

The authorised capital of the company has increased from Rs.40,00,000/-( Rupees Forty Lacs only) to Rs.2,00,00,000/- (Rupees Two crore only) by creation of 16,00,000 (Sixteen Lacs) New equity shares of Rs.10/- (Rupees Ten only) each. Consequently, Clause V of the Memorandum of Association and Article 3 (a) of the Articles of Association of the Company is proposed to be altered.

A Copy of Memorandum and Articles of Association of the Company together with the proposed alteration will be made available for inspection by the Members of the Company at its Registered office between 11:00 a.m. and 1:00 p.m. on any working day of the Company till the date of Annual General Meeting.In terms of the provisions of Section (s) 16, 31and 94 consent of the Members is required for any alteration in Memorandum and Articles of Association of the Company. The Board recommends the Resolutions for your approval.Under section 293(1)(d) of the Companies Act, 1956, the Board of Directors cannot except with the consent of the Company borrow moneys apart from temporary loans obtained from the Company's bankers in the ordinary course of business in excess of the aggregate of paid-up capital and free reserves of the Company, that is to say, reserves not set apart for any specific purpose.

Certainly, the competition is intensifying in all activities as the generic medicine business of institutional supply progresses towards market dominated by big pharmaceutical players.  Presently our activities are generally on institutional supply and hope that in next year the present annual figures should surpass those for current year.

The governing body of any organisation behaves just as if Stone Age Men, who may not have been the stoic, macho, callous wooly mammoth hunters we envision them to be in the popular imagination, but they have suffered a lot and bear the burden of pain for the progress of civilised society. In the same way your association with company depends how both treat one another, not only in the past, but also in the present-is determined largely by situation, context, and the demands of the promoter's perception about the image of our company.

It is our firm conviction that your company is destined to follow the innovated governance path of the organizational development strength in a competitive pharmaceutical market. Lord Krishna said- "Learn to be like a lotus that stands unmoved and untouched by the dirt in which it grows", In the context of above stated facts we at 'Oriscon Biotech (I) Pvt Ltd' always endeavor Promoters and company's friendship are the lotus that will continue to stand amidst the filthy politics forever, untouched and unmoved. We also hope that our symbol (The Flagship of Oriscon Biotech (I) Pvt Ltd) is perhaps the symbolic representation of our this relationship, which should flourish as an Extended United Family.

We should always remember that, "LIFE is always an eternal struggle for a leader, who never copycats. We, The Board of directors, in a collective way always ready to accept our Full 100% responsibility, no matter what happens in our progressive lifespan, we have something to do with it with a positive set of mind. On the other hand, the promoters group of our company should have to increase their cognitive abilities such as enhanced visual and auditory sensitivity to judge emphatically the performance of our past along with prospects for future.

We should take the Lesson from Bhagavad-Gita; (Chapter 2: Verse - 47): Perform your duty with a mind free from the anxieties of fruits of action. Neither you be indolent nor consider yourself as the cause (agent) of results.

Once again, I am congratulating all the Promoters/Members & Financers of the company for reposing confidence in the Governance of the Company and providing me a trouble free time in the past operational years since 2006. Further, I would like to assure all of you that the department of HRD will take note of all the facts & suggestions put forward by all of you and promptly take remedial steps for your complete satisfaction.

Finally, may I express my gratitude to my fellow directors for their guidance, sincerity and application during the past year .Your company intend to keep it so in future also.

Thank you for your obvious interest indicated by your presence here today. I hope you approve of this year's Annual General Meeting 2015.

For and on behalf of the Board


 <[ Signature Digital ]>

Priya Ranjan Shrivastava                                                                      ( Chairman &  Managing  Director)